Live Chat ×
Skip to main content

Diagnostic Pathology Update 2017

Evaluated by: David B. Kaminsky, M.D., FIAC, November 8, 2017
Original release date: November 8, 2017
Access to this course expires on: July 16, 2020, at 11:59 PM Pacific Time

Course Description
USCAP’s Diagnostic Pathology Update course is uniquely designed to take your practice to the next level and challenge your imagination. While content is designed to close practice gaps and reinforce skills, the setting encourages a family opportunity to learn in a magnificent environment with time to explore the harbor, the town and the culture of Halifax.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Recognize mimics, variants and pitfalls in prostate pathology; distinguish primary from secondary cancers; understand utility and pitfalls of immunohistochemical stains; know the importance of recent changes in Gleason grading
  • Improve performance and reduce diagnostic errors in the analysis of problematic non-invasive breast lesions, incorporating strategies that combine morphology, ancillary studies and informed analytic approaches
  • Recognize the predominant cytologic patterns exhibited by commonly encountered soft tissue tumors; formulate differential diagnoses; understand the clinical context of histologic findings; integrate ancillary tests and understand their strengths and limitations
  • Provide a combined approach to contemporary thyroid diagnosis utilizing cytomorphology, histologic architecture and molecular studies

Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 21 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 21 SAM/Part II credit hours.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships:  Adam Bagg, M.D., Rhonda Yantiss, M.D., Steven D. Billings, M.D., Daniel J. Brat, M.D., Ph.D., Laura C. Collins, M.D., Jennifer Hunt, M.D., David B. Kaminsky, M.D., FIAC, Marisa R. Nucci, M.D., Victor E. Reuter, M.D.

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME and SAM credit, all learners must complete the evaluation. Your certificate will be available to view and print by clicking  here.

Buy the entire 2017 Diagnostic Pathology Update and get a great discount!

Not A Member? Click Here